Landmark legislation in Italy: Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs
FDA approves first drug to improve growth in children with most common form of Dwarfism
NICE creates new menu of treatment options for those suffering from depression
Introduction The EU Joint Clinical Assessment (JCA) was introduced to reduce duplication and establi...
As NICE and EU Joint Clinical Assessment (JCA) requirements increasingly need to be considered in pa...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.